These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6115310)

  • 1. [Newborn screening for Duchenne muscular dystrophy (author's transl)].
    Grimm T
    Monatsschr Kinderheilkd; 1981 Jul; 129(7):414-7. PubMed ID: 6115310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening.
    Hauser E; Toifl K; Mad A; Bittner R
    Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study.
    Hutton EM; Thompson MW
    Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)].
    Plauchu H; Cordier MP; Carrier HN; Dellamonica C; Dorche C; Guibaud P; Lauras B; Cotte J; Robert JM
    J Genet Hum; 1987 Aug; 35(4):217-30. PubMed ID: 3655748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy].
    Beckmann R; Scheuerbrandt G
    Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus.
    Drousiotou A; Ioannou P; Georgiou T; Mavrikiou E; Christopoulos G; Kyriakides T; Voyasianos M; Argyriou A; Middleton L
    Genet Test; 1998; 2(1):55-60. PubMed ID: 10464597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies about Duchenne muscular dystrophy. (1) Neonatal screening.
    Gardner-Medwin D
    Dev Med Child Neurol; 1979 Jun; 21(3):390-3. PubMed ID: 467822
    [No Abstract]   [Full Text] [Related]  

  • 13. Newborn screening for Duchenne muscular dystrophy.
    Zellweger H; Antonik A
    Pediatrics; 1975 Jan; 55(1):30-4. PubMed ID: 1110862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and genetic counselling of subclinical and carrier states in Duchenne muscular dystrophy.
    Das PK; Sen SK
    Eur Neurol; 1979; 18(2):91-5. PubMed ID: 456392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systematic neonatal screening for Duchenne muscular dystrophy].
    Dellamonica C; Robert JM; Cotte J; Plauchu H; Dorche C
    Nouv Presse Med; 1979 Apr; 8(18):1491-3. PubMed ID: 471723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene studies in newborn males with Duchenne muscular dystrophy detected by neonatal screening.
    Greenberg CR; Rohringer M; Jacobs HK; Averill N; Nylen E; van Ommen GJ; Wrogemann K
    Lancet; 1988 Aug; 2(8608):425-7. PubMed ID: 2900355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased incidence of Duchenne muscular dystrophy in western Japan 1956-1980.
    Takeshita K; Kasagi S; Mito T; Tanaka T; Ootani K
    Neuroepidemiology; 1987; 6(3):130-8. PubMed ID: 3658082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of muscular dystrophies.
    Harper PS
    Prog Med Genet; 1985; 6():53-90. PubMed ID: 3915367
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of serum creatine kinase estimation with short tandem repeats based linkage analysis in carriers and affected children of Duchenne muscular dystrophy.
    Hashim R; Shaheen S; Ahmad S; Sattar A; Khan FA
    J Ayub Med Coll Abbottabad; 2011; 23(1):125-8. PubMed ID: 22830166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of preclinical Duchenne's muscular dystrophy in the newborn using the CK screening test].
    Beckmann R; Scheuerbrandt G; Antonik A
    Monatsschr Kinderheilkd (1902); 1976 Sep; 129(9):658-9. PubMed ID: 979985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.